High-intensity Interval Training Vs. Moderate-intensity Continuous Exercise Training in Heart Failure with Preserved Ejection Fraction: a Pilot Study
Overview
Authors
Affiliations
Heart failure with preserved ejection fraction (HFpEF) is a major cause of morbidity and mortality. Exercise training is an established adjuvant therapy in heart failure; however, the effects of high-intensity interval training (HIIT) in HFpEF are unknown. We compared the effects of HIIT vs. moderate-intensity aerobic continuous training (MI-ACT) on peak oxygen uptake (V̇o₂peak), left ventricular diastolic dysfunction, and endothelial function in patients with HFpEF. Nineteen patients with HFpEF (age 70 ± 8.3 yr) were randomized to either HIIT (4 × 4 min at 85-90% peak heart rate, with 3 min active recovery) or MI-ACT (30 min at 70% peak heart rate). Fifteen patients completed exercise training (HIIT: n = 9; MI-ACT: n = 6). Patients trained 3 days/wk for 4 wk. Before and after training patients underwent a treadmill test for V̇o₂peak determination, 2D-echocardiography for assessment of left ventricular diastolic dysfunction, and brachial artery flow-mediated dilation (FMD) for assessment of endothelial function. HIIT improved V̇o₂peak (pre = 19.2 ± 5.2 ml·kg(-1)·min(-1); post = 21.0 ± 5.2 ml·kg(-1)·min(-1); P = 0.04) and left ventricular diastolic dysfunction grade (pre = 2.1 ± 0.3; post = 1.3 ± 0.7; P = 0.02), but FMD was unchanged (pre = 6.9 ± 3.7%; post = 7.0 ± 4.2%). No changes were observed following MI-ACT. A trend for reduced left atrial volume index was observed following HIIT compared with MI-ACT (-3.3 ± 6.6 vs. +5.8 ± 10.7 ml/m(2); P = 0.06). In HFpEF patients 4 wk of HIIT significantly improved V̇o₂peak and left ventricular diastolic dysfunction. HIIT may provide a more robust stimulus than MI-ACT for early exercise training adaptations in HFpEF.
New Types of Post-Translational Modification of Proteins in Cardiovascular Diseases.
Fang J, Wu S, Zhao H, Zhou C, Xue L, Lei Z J Cardiovasc Transl Res. 2025; .
PMID: 40032789 DOI: 10.1007/s12265-025-10600-7.
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities.
Vacca A, Wang R, Nambiar N, Capone F, Farrelly C, Mostafa A Heart Fail Rev. 2024; .
PMID: 39283525 DOI: 10.1007/s10741-024-10439-1.
Liang W, Wang X, Cheng S, Jiao J, Zhu X, Duan Y Sports Med Open. 2024; 10(1):98.
PMID: 39266933 PMC: 11393274. DOI: 10.1186/s40798-024-00767-9.
Alshamari M, Kourek C, Sanoudou D, Delis D, Dimopoulos S, Rovina N Rev Cardiovasc Med. 2024; 24(1):29.
PMID: 39076879 PMC: 11270399. DOI: 10.31083/j.rcm2401029.
Aispuru-Lanche G, Gallego-Munoz M, Jayo-Montoya J, Villar-Zabala B, Maldonado-Martin S Rev Cardiovasc Med. 2024; 24(1):20.
PMID: 39076876 PMC: 11270403. DOI: 10.31083/j.rcm2401020.